# Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients

> **NCT04587856** · NA · RECRUITING · sponsor: **Gruppo Italiano Malattie EMatologiche dell'Adulto** · enrollment: 38 (estimated)

## Conditions studied

- Myelodysplastic Syndromes

## Interventions

- **OTHER:** bone marrow withdrawal

## Key facts

- **NCT ID:** NCT04587856
- **Lead sponsor:** Gruppo Italiano Malattie EMatologiche dell'Adulto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-02-12
- **Primary completion:** 2025-03
- **Final completion:** 2025-03
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2024-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04587856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04587856, "Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04587856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*